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Abstract
Resolving distinct biochemical interaction states when analyzing the trajectories of diffusing
proteins in live cells on an individual basis remains challenging because of the limited statis-
tics provided by the relatively short trajectories available experimentally. Here, we introduce
a novel, machine-learning based classification methodology, which we call perturbation
expectation-maximization (pEM), that simultaneously analyzes a population of protein tra-
jectories to uncover the system of diffusive behaviors which collectively result from distinct
biochemical interactions. We validate the performance of pEM in silico and demonstrate
that pEM is capable of uncovering the proper number of underlying diffusive states with an
accurate characterization of their diffusion properties. We then apply pEM to experimental
protein trajectories of Rho GTPases, an integral regulator of cytoskeletal dynamics and cel-
lular homeostasis, in vivo via single particle tracking photo-activated localization microcopy.
Remarkably, pEM uncovers 6 distinct diffusive states conserved across various Rho
GTPase family members. The variability across family members in the propensities for
each diffusive state reveals non-redundant roles in the activation states of RhoA and RhoC.
In a resting cell, our results support a model where RhoA is constantly cycling between acti-
vation states, with an imbalance of rates favoring an inactive state. RhoC, on the other
hand, remains predominantly inactive.
Author Summary
Single particle tracking is a powerful tool that captures the diffusive dynamics of proteins as
they undergo various interactions in living cells. Uncovering different biochemical interac-
tions by analyzing the diffusive behaviors of individual protein trajectories, however, is
challenging due to the limited statistics provided by short trajectories and experimental
noise sources which are intimately coupled into each protein’s localization. Here, we intro-
duce a novel, unsupervised, machine-learning based classification methodology, which we
call perturbation expectation-maximization (pEM), that simultaneously analyzes a
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population of protein trajectories to uncover the system of diffusive behaviors which collec-
tively result from distinct biochemical interactions. We validate the performance of pEM in
silico and in vivo on the biological system of Rho GTPase, a signal transduction protein
responsible for regulating cytoskeletal dynamics. We envision that the presented methodol-
ogy will be applicable to a wide range of single protein tracking data where different bio-
chemical interactions result in distinct diffusive behaviors. More generally, this study
brings us an important step closer to the possibility of monitoring the endogenous bio-
chemistry of diffusing proteins within live cells with single molecule resolution.
This is a PLOS Computational BiologyMethods paper
Introduction
As critical regulators of cytoskeletal dynamics, Rho family GTPases play numerous roles in
normal biological processes and their dysregulation drives the progression of multiple patho-
logical conditions, notably cancer [1–4]. The Rho subfamily consists of RhoA and RhoC,
which are 85% identical in sequence, with much of their sequence divergence occurring in the
C-terminal hypervariable domain [5]. Despite such high sequence homology, several reports
indicate that RhoA and RhoC are not redundant [6–13]. For instance, RhoA is often inhibitory
while RhoC facilitates cancer cell invasion [8–12]. Moreover, while RhoA is able to transform
mouse fibroblasts in culture and enhance tumor formation by these cells in mice, RhoC is
unable to do so [13].
A simplified model, which captures the main components of Rho GTPases’ activation cycle,
is displayed in Fig 1. Rho guanine dissociation inhibitors (RhoGDIs) sequester Rho proteins in
the cytoplasm, curtailing its activity. Numerous signaling cascades, however, lead to dissociation
of this complex, driving Rho to associate with the plasma membrane. On the membrane, Rho
Fig 1. Diagram of Rho activation model. Rho can be found sequestered in the cytosol through association with RhoGDI. Otherwise, when not bound to
RhoGDI, Rho is associated with the cell membrane. When diffusing on the membrane, RhoGEFs catalyze the exchange of GDP with GTP. Active GTP
bound Rho freely diffuses as a single protein and associates with numerous downstream effectors as well as macromolecular complexes. Rho signaling is
terminated by binding to RhoGAP, which facilitates the hydrolysis of GTP. The freely diffusing inactive RhoAmay then reenter the cycle or be sequestered to
the cytosol by RhoGDI.
doi:10.1371/journal.pcbi.1004297.g001
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becomes activated when the GDP is exchanged for GTP. This process is catalyzed by Rho gua-
nine nucleotide exchange factors (RhoGEFs). In its active form, Rho may perform its function
with various downstream effectors. The activation cycle is completed with the hydrolysis of
GTP which is catalyzed by Rho GTPase activating proteins (RhoGAPs), returning Rho back to
an inactive GDP form. In this model, Rho is constantly cycling between activation states [14–
16]. RhoGEFs and RhoGAPs work in an antagonistic fashion to regulate the activation of Rho.
The net balance of these activities favors the GDP-bound form in the resting state of the cell.
Exogenous stimulation may then shift the equilibrium of nucleotide states towards an increase
in the GTP-bound form through concomitant activation of GEFs and inhibition of GAPs [16].
How these interactions manifest inside live cells, however, remain poorly understood.
Recent advances in live cell imaging have now made it possible to non-invasively monitor
the motions of individual proteins inside living cells [17]. Specifically, single particle tracking
photoactivated localization microscopy (sptPALM) stochastically photoconverts a subset of
fluorescently labeled proteins within a high population density, facilitating the unambiguous
tracking of individual proteins simultaneously. Each resultant protein trajectory contains infor-
mation on the protein’s interactions with the local environment, which includes the material
properties of the diffusing medium, presence of a net flow, and spatial confinement. In addi-
tion, the underlying diffusivity may change when the protein is associated to other proteins or
when it undergoes a conformational change, which alters its radius of gyration. In essence, the
diffusion of a protein can act as a reporter, not only of the protein’s local environment, but also
of the protein’s biochemical state. In this context, it is intriguing to consider the possibility of
being able to reconstruct Rho’s interactions and biochemistry, and thus its biological roles,
using the membrane-associated dynamics of individual Rho proteins inside live cells.
Quantitatively characterizing the information provided by single protein trajectories
acquired via sptPALM, however, is challenging due to the limited statistics arising from the
photoinstability of the fluorescent probes, which result in a premature truncation of the
observed protein trajectories [18]. In addition, experimental noise sources obscure the true
instantaneous positions of each diffusing protein via “static” [19–21] and “dynamic” localiza-
tion noise [19]. Static localization noise results from the limited number of photons emitted by
a fluorophore within the camera’s exposure time. Dynamic localization noise results from the
protein’s diffusion during the camera’s exposure time, which in turn, creates motion blur. The
resultant short, noisy protein trajectories demand statistically-correct analyses that properly
account for these experimental noise sources so that the underlying protein motions—and
hence the underlying biology—can be characterized as accurately as possible.
Due to the limited statistics of short protein trajectories, characterization of the long-time
diffusive behavior, which manifests interactions with the environment leading to confinement,
flow, or anomalous diffusion, remains challenging (S1 Text). Thus, it is common to focus on
the short-time diffusive dynamics, which describe the protein’s micro-diffusion prior to these
interactions, which presumably occur on longer time-scales [22–24]. In theory, short-time dif-
fusion analysis allows for the determination of biochemical interaction states due to protein-
protein and protein-lipid interactions. In practice, the short-time diffusivity is traditionally
quantified by fitting the first few time lags of the mean squared displacement (MSD) from an
individual protein trajectory [17, 25–29]. However, due to the stochastic nature of diffusion,
the resulting distribution of short-time diffusion coefficients from a collection of protein trajec-
tories tends to be difficult to interpret, especially when the track lengths are short (S1 Text).
Moreover, protein species that collectively exhibit heterogeneous diffusive behaviors arising
from different biochemical interaction states, as would be expected for Rho proteins, yield an
even more complex distribution comprised of a mixture of component distributions each gen-
erated by a distinct diffusive state.
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The simplest strategy for resolving the diffusive states within a collection of heterogeneous
protein trajectories is to apply a least squares fit to the cumulative distribution of the popula-
tion of protein track displacements with a multi-component cumulative distribution function
(CDF), in which each component represents a set of Gaussian-distributed displacements [30]
—a Gaussian being the propagator for normal diffusion [31]. Alternatively, variational Bayes
single particle tracking (vbSPT) has been recently introduced to uncover the number and prop-
erties of normal diffusive states and their corresponding transition kinetics between each state
[32]. CDF and vbSPT, however, make an implicit assumption that each displacement of the
protein trajectory is independent. Even though this assumption is theoretically consistent with
the Markovian nature of normal diffusion [33], experimental protein track displacements are,
in fact, not Markovian as a result of correlations between nearest-neighbor displacements,
which inevitably arise as a result of static and dynamic localization noise [34].
Here, we introduce and expound a novel machine-learning-based classification methodol-
ogy, which we term perturbation expectation-maximization (pEM), that simultaneously ana-
lyzes a population of protein trajectories, accounting for the experimental correlations in a
statistically-correct fashion, to uncover the system of biochemical interactions which collec-
tively result in distinct diffusive behaviors, each defined by an underlying diffusivity and static
localization noise. We first validate the performance of pEM against various sets of synthetic
protein trajectories containing static and dynamic localization noise under realistic conditions.
We illustrate how pEM performance depends on the number of protein trajectories and com-
pare its performance with CDF and vbSPT. We then apply pEM to experimental protein trajec-
tories of Rho GTPase in live cells acquired via sptPALM.
Remarkably, our pEM methodology uncovers six normal diffusive states, each with a diffu-
sivity and static localization noise, that appear conserved across RhoA and RhoC, and their var-
ious functional mutants. These Rho GTPase family members, however, yield significant
variability in their propensity for each of the diffusive states, revealing non-redundant roles for
RhoA and RhoC. In a minimally stimulated cell, we find that activation of RhoA alone does
not drive binding to large macromolecular complexes, whereas RhoC activation results in a sig-
nificant rise in population into these complexes. In an unstimulated cell, our results support a
model where RhoA constantly cycles between activation states with an imbalance in transition
rates favoring inactive states. RhoC, on the other hand, remains predominantly inactive.
The pEMmethodology introduced in this paper will be broadly applicable to a variety of
biological systems, whenever different biochemical interactions manifest as distinct diffusive
behaviors. More generally, pEM brings us an important step closer to the possibility of moni-
toring the endogenous biochemistry of diffusing proteins within live cells with single molecule
resolution.
Materials and Methods
Maximum likelihood framework for a collection of diffusive states
Our classification procedure to uncover the system of biochemical interactions is based on
determining the diffusive state of each interaction. Specifically, we employ a systems-level like-
lihood function, given by a Gaussian mixture model (GMM) of multivariate Gaussians, to
account for the different diffusion coefficients and static localization noises which collectively
result from different biochemical interactions experienced across a population of protein
trajectories.
For a collection ofM one-dimensional (1D) protein track displacements undergoing normal
diffusion with K underlying diffusive states, the systems-level likelihood function, or,
Diffusive States of Rho GTPase
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equivalently, the log-likelihood function is given by (see S2 Text for derivation):
lnLðDx^jp^; S^Þ ¼
XM
m¼1
ln
XK
k¼1
pkPðDxmjSkÞ
( )
; ð1Þ
where Δxm represents the vector of Nm displacements for protein trajectorym,
Dxm ¼ fDxmðnÞgNmn¼1, Dx^ ¼ fDxmgMm¼1 is the set ofM protein track displacements, π^ ¼
fpkgKk¼1 is the set of variables which represent the fraction of the population of trajectories that
realize diffusive state k, which is bounded and normalized: 0 πk 1 and
PK
k¼1 pk ¼ 1, S^ ¼
fSkgKk¼1 is the set of covariance matrices which deﬁnes each diffusive state, and P(ΔxmjSk) is
the likelihood of protein trajectorym given by [34]:
PðDxmjSkÞ ¼
1
ð2pÞNm=2jSkj1=2
exp  1
2
DxTmS
1
k Dxm
 
; ð2Þ
where DxTm is the transpose, Sk is the covariance matrix for diffusive state k, jSkj is its determi-
nant, and S1k is its inverse. Explicitly, the covariance matrix for a vector of displacements sepa-
rated by Δt undergoing normal diffusion is given by [34]:
Skði; jÞ ¼
2DkDt þ 2s2k  4RDkDt i ¼ j
s2k þ 2RDkDt i ¼ j 1
0 otherwise
ð3Þ
8><
>:
where i and j correspond to the row and column indices of the covariance matrix, respectively,
Dk is the diffusion coefﬁcient for diffusive state k, σk is the static localization noise for diffusive
state k, and R is the motion blur coefﬁcient [19, 34], which depends on the shutter state during
the camera integration time. For a protein trajectory undergoing normal diffusion, R  1
6
DtE
Dt ,
where ΔtE is the exposure time [35]. For a shutter that is open throughout Δt, as we assume in
this paper, R ¼ 1
6
.
Our goal is to determine the values of fDk; sk; pkgKk¼1 that maximize Eq 1. Fortunately,
GMMs are efﬁciently maximized with the expectation-maximization (EM) algorithm [36, 37].
In the expectation step, the posterior probability, γmk, that protein trajectorym realizes diffu-
sive state k given the covariance matrices of each diffusive state, Sk, is calculated according to:
gmk ¼
pkPðDxmjSkÞXK
j¼1 pjPðDxmjSjÞ
: ð4Þ
In the maximization step, the posterior probability is used to update the parameter estimates
by first maximizing Eq 1 with respect to Sk and then solving for Dk based on the systems-level
covariance-based estimator (CVE) which leads to the expression (see S2 Text for derivation):
Dk ¼
1
2DtMk
XM
m¼1
gmkðhDxmðnÞ2i þ 2hDxmðnÞDxmðnþ 1ÞiÞ ð5Þ
where
hDxmðnÞ2i ¼
1
Nm
XNm
n¼1
DxmðnÞ2
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is the mean square displacement of the Nm displacements of trajectorym,
hDxmðnÞDxmðnþ 1Þi ¼
1
Nm  1
XNm1
n¼1
DxmðnÞDxmðnþ 1Þ
is the mean correlation between nearest-neighbor displacements of trajectorym and
Mk ¼
XM
m¼1
gmk:
Similarly, the covariance-based maximization expression for s2k is given by:
s2k ¼
1
2Mk
XM
m¼1
gmkhDxmðnÞ2i  DkDtð1 2RÞ: ð6Þ
We also maximize Eq 1 with respect to the population fraction of each diffusive state, πk, with
the result that
pk ¼
Mk
M
: ð7Þ
Because the posterior probabilities, γmk, depend on Dk, σk, and πk, Eqs 5, 6 and 7 constitute
coupled, non-linear equations for Dk, σk, and πk, respectively. The EM algorithm solves these
equations iteratively [37]. In brief, the current estimates for the parameters, Dk, σk, and πk, are
used to generate the analytical covariance matrix (Eq 3), which is used in the expectation step
to evaluate the posterior probabilities (Eq 4). Then, the maximization step uses the posterior
probabilities to re-estimate Dk (Eq 5), σk (Eq 6), and πk (Eq 7). This procedure is iterated, until
the change in the log-likelihood becomes smaller than a set threshold [37].
The extension to higher dimensions can be carried out facilely by treating each dimension
separately. In this paper, we assume that protein trajectories undergo isotropic diffusion.
Hence, we calculate the expectation step by averaging the posterior probability over each
dimension using the same parameter estimates. For the maximization step, the maximized
parameter estimates are calculated separately for each dimension and then averaged. At each
step in the iteration procedure, the complete log-likelihood is calculated by summing the log-
likelihood from each dimension.
Perturbation expectation-maximization
Although the EM algorithm guarantees convergence to a maximum [37], convergence to the
global maximum is not guaranteed. It turns out that global convergence is highly dependent on
the initial parameter values for Dk, σk, and πk[38], and although the initialization sensitivity
may be remedied by re-employing EM with a different set of initial parameters, this approach
is very computationally expensive as it requires a large number of reinitialization trials to suffi-
ciently explore parameter space. By contrast, we elect to employ a novel variant of the EM, that
we term perturbation Expectation-Maximization (pEM), to directly handle EM convergence
issues (S1 Data).
Initially, our pEM procedure employs the EM algorithm on the original set of protein trajec-
tories with random initial parameter values. The mechanism by which pEM escapes from a
local maximum is by reemploying the EM on a perturbed likelihood surface, which is generated
with a Monte Carlo bootstrap set of the original protein trajectories [39]. Specifically, in each
perturbation trial, the original protein trajectories are randomly sampled to create a new data
set, with the same total number of trajectories as the original data set; however, some protein
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trajectories may be counted more than once, while other protein trajectories are excluded alto-
gether. Consequently, each perturbation slightly alters the likelihood surface with the aim that
a local maximum may no longer be a maximum in the perturbed likelihood surface. Since the
perturbed likelihood surface may shift the location of the global maximum likelihood, we then
verify whether a higher likelihood has truly been found by calculating the likelihood using the
pEM-converged parameters with the original dataset. If the pEM-converged parameters indeed
yield a higher likelihood, then the EM parameters are updated by reemploying the EM algo-
rithm initialized with the pEM parameter estimates on the original dataset. Otherwise, the
pEM estimates remain unchanged and we continue to perturb the likelihood surface with dif-
ferent Monte Carlo bootstrap datasets in search of an escape route. This process is repeated
until a predetermined number of perturbations have been executed and yield no advance. The
verification step guarantees only upwards movements along the unperturbed likelihood surface
are permitted. When the global maximum is reached, each pEM trial terminates quickly as a
higher likelihood cannot be found.
To generate each set of random initial values, K random numbers between 0 and 1 are
drawn from a uniform distribution. The initial population fractions, fp0kgKk¼1, are given by nor-
malizing these random numbers so that the sum is equal to 1. The initial diffusivity values are
set using the initial randomly-chosen population fractions and the empirical cumulative diffu-
sivity distribution function. By dividing the cumulative distribution function into K regions
proportional to the initial population fractions, the initial value of the diffusivity of diffusive
state k (D0k) is then picked as the diffusivity corresponding to the midpoint of region k of the
cumulative probability distribution, namely to
Pk1
j¼1 p
0
j þ
p0
k
2
. The initial static localization noise
values are set to the mean CVE static localization noise estimates for each diffusive state. Thus,
we achieve an initialization that serves as a non-parametric method to randomly sample from
the observed distribution of diffusion coefﬁcients.
Since the number of diffusive states is not known a priori, we repeat the pEM procedure for
different numbers of diffusive states, finding the maximum likelihood in each case. However,
the likelihood increases monotonically with increasing number of free parameters [36]. In
other words, the maximum likelihood does not penalize for model complexity, which may lead
to over-fitting. To maintain model parsimony, we employ the Bayesian Information Criterion
(BIC) to penalize for the inclusion of additional diffusive states according to [36, 39]:
BIC ¼ lnL K lnM
where L is the maximum likelihood value, K is the assumed number diffusive states, andM is
the number of protein trajectories. In this formulation, the model with the largest BIC score is
selected.
Generation of expression vectors
Generation of the pcDNA6/His-mEos2-Rho expression construct was achieved by classical
molecular biology techniques. In brief, the coding sequence for mEos2 was extracted from a
pSERTa-mEos2 vector (Addgene plasmid 20341) by digestion with BamHI and EcoRI (Pro-
mega, Madison, WI) restriction enzymes. The resulting coding DNA fragment was ligated into
BamHI and EcoRI digested and alkaline phosphatase (Promega) treated pcDNA6/His-C (Life
Technologies, Carlsbad, CA) vector. A c-terminal TGA stop codon carried in by the mEos2
coding sequence was mutated to GGA following a standard Stratagene quick change method.
The Rho coding sequence was PCR amplified from a pTAG-RFP-RhoA expression vector (pro-
vided by Dr. William Cain) by PFU Ultra II DNA polymerase (Agilent Technologies, Santa
Diffusive States of Rho GTPase
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Clara, CA) and the following phosphorylated primers: 5’-CCGACCATCCTCCAAAATC-3’
and 5’-GGATCCCTCCAGCAAGGT-3’ (Integrated DNA Technologies, Coralville, IA). The
resulting PCR Rho fragment was blunt end ligated into EcoRV digested and alkaline phospha-
tase treated pcDNA6/his-mEos2 plasmid DNA. The resulting pcDNA6/His-mEos2-Rho vector
was confirmed by Sanger sequencing.
Cell culture and transfection
MCF10A cells were obtained from ATCC (Manassas, VI) and maintained in Dulbecco’s Modi-
fication of Eagle’s Medium/Ham’s F-12 50/50 medium (Cellgro, Manassas, VI) containing 5%
fetal bovine serum, 50 μg/mL Bovine Pituitary Extract (Sigma Aldrich), 0.5 μg/mL hydrocorti-
sone (Sigma Aldrich), 20 ng/mL human Epidermal Growth Factor (Sigma Aldrich), 10 μg/mL
insulin (Sigma Aldrich), 100 ng/mL cholera toxin (Sigma Aldrich) and 1% penicillin/strepto-
mycin (Cellgro). 24hrs prior to transfection cells were plated at a confluence of 80% in 8-well
nunc chambers (Lab-Tek). Transfections were carried out using X-tremeGENE HP transfec-
tion reagent (Roche) following manufacture’s recommended protocol and a transfection ratio
of 4:1 (reagent:DNA). Cells were used for imaging 24 hours post transfection.
Imaging setup
A custom built total internal reflection fluorescence (TIRF) system is assembled upon a Zeiss
Axio Observer A1 body. Sample position is controlled by Physik Instrumente stage controller
(C867). The system has 4 diode lasers used for fluorescence excitation: 50 mW 404 nm (Coher-
ent Cube), 30 mW 488 nm (Coherent Sapphire), 50 mW 561 nm (Coherent Sapphire), and a
50 mW 642 nm (Coherent Cube). All four laser intensities are modulated by an acousto-optic
tunable filter (AA Optical Electronic). The laser lines are expanded by a 5X beam expander and
diverted to the back objective aperture with a quad dichroic filter (Semrock, Di01-R405/488/
561/635). A movable achromatic doublet lens is used to focus the expanded beam onto the
back focal plane of a 100X NA 1.46 Zeiss Plan Apo objective. TIRF is accomplished by translat-
ing the lens to the peripheral of the objective back aperture such that the emerging beam
exceeds the total internal reflection critical angle. Excitation light is removed by a quad notch
filter (Semrock NF01-405/488/557/640). The field of view is magnified 2X after the tube lens
and the fluorescence image is projected on an Andor iXon DU897 EMCCD camera. Custom
software was written in LabView (National Instruments) to control the camera, laser intensity,
laser duration and image acquisition. Cells are maintained inside a stage incubator at 37C
(Zeiss, TempControl 37–2) and 5% CO2 perfusion (Zeiss, CTI-Controller 3700) during imag-
ing. The each cell was prebleached with 561 nm laser to remove background. Then, the samples
were exposed to the 405 nm laser for 500 ms. Movies were taken subsequently at a frame rate
of 31 Hz with a TIRF illumination created by the 561 nm laser.
Single molecule pull down assay
Nunc Lab-Tek II chamber slides were cleaned with 1M NaOH. Mouse anti-human RhoA was
incubated with glass (1 μg/mL) for 1 hour. Unbound glass was blocked with 5% BSA for 1hr.
HEK293T cell lysates containing mEos2-RhoA where incubate with antibody coated glass for
30 min and then washed with 1xPBS three times. Imaging was in PBS, areas were prebleached
with 561 nm laser to remove background, then samples were photoconverted to reveal single
molecule mEos2.
Diffusive States of Rho GTPase
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Live cell protein tracking
Localization of individual Rho proteins was accomplished by placing each raw image through a
spatial bandpass filter. The location of the peaks above a given threshold value were found and
coarsely localized with a centroid moment calculation. Accurate localization estimates were
then found by fitting each centroid to a radially symmetric Gaussian function [21]. The local-
ized positions of the molecules in each frame are linked with a commonly used tracking algo-
rithm for single protein tracking [17, 40]. The two user inputs the algorithm requires in order
to link the protein positions are: the minimum number of frames, which constitute a trajectory,
and the maximum distance a protein can travel from one frame to the next, which were set to
15 steps and 5 pixels (860 nm), respectively. These are typical values for sptPALM [17].
Protein trajectory simulation procedure
Synthetic protein trajectories undergoing isotropic Brownian motion were constructed with
the recursion [31]: xi+1 = xi + (2DΔt)
1/2Wi with x1 = 0, where D is the diffusion coefficient, Δt
is the time interval between positions, andWi is a normally distributed random number with
zero mean and unit variance. This process is carried out separately for two spatial dimensions
and then combined to form the true two-dimensional (2D) synthetic protein trajectory. Motion
blur is incorporated by simulating “micro-step” displacements for 1 ms time steps and averag-
ing 32 successive positions. The net effect assumes that the exposure time is equal to the frame
duration. Static localization noise is included by adding a normally distributed random number
with zero mean and variance, s2sim, to each motion-blurred position.
To recapitulate the track-length variability found in our experimental data, the length of
each simulated trajectory is a random variable, N, given by N = (Nmax−Nmin)exp[−rZ] + Nmin,
where r = (Nmax−Nmin)/(hNi−Nmin); Nmax is the maximum length that a protein trajectory can
realize and is set to 60; Nmin is the minimum length and is set to 15; hNi is the average protein
track length and is set to 25; Z is a uniform random number between 0 and 1. To create a col-
lection ofM heterogeneous protein trajectories, for each value of k, psimk M random-length
tracks were simulated with a diffusion constant Dsimk and static localization noise s
sim
k .
Results
pEM performance in silico
To understand the strengths and limitations of pEM, it is necessary to appreciate the factors
that contribute to the complexity of the system under study, which include: a large number of
diffusive states; diffusive states with similar diffusivities, leading to overlapping component dis-
tributions; component distributions with small population fractions, leading to under-repre-
sentation; and a restricted number of protein trajectories, leading to poorly defined component
distributions. To elucidate the roles of these factors, we have generated three cases of synthetic
protein trajectories, whose parameters are given in S1 Table: case 1 represents a relatively sim-
ple dataset, comprising four more-or-less non-overlapping and well-represented diffusive
states (Fig 2a, left); case 2 represents a somewhat more complex dataset, comprising four over-
lapping but well-represented states (Fig 2a, middle); case 3 represents a very complex dataset,
comprising protein trajectories containing 7 underlying diffusive states which include a num-
ber of overlapping and/or under-represented components (Fig 2a, right). To further test the
capabilities of pEM, we apply different levels of static localization noise for each diffusive state,
which may be realized experimentally as a consequence of dimerization or partial-quenching
arising from either binding interactions or conformational changes. In S3 Text, we provide a
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detailed discussion of pEM’s improved estimation and efficiency over the alternative approach
where multiple runs of the EM are performed with different initial parameters.
We explore how pEM performance depends on the number of protein trajectories, by vary-
ing the number of trajectories from a minimum of 500 to a maximum of 10,000 trajectories for
case 1 and case 2, and from a minimum of 1,000 to a maximum of 15,000 trajectories for case 3
(see S1 Fig. for example trajectories). Remarkably, pEM was able to recover the correct number
of diffusive states and assign reasonably accurate parameter values for all of the data sets of
case 1, regardless of the number of trajectories analyzed (Fig 2b-2d, left). Even more remark-
ably, pEM was able to uncover the correct number of diffusive states with accurate parameter
values for case 2, even for as few as 500 trajectories (Fig 2b-2d, middle). Clearly, the BIC is
capable of reliably determining the number of diffusive states with high fidelity in these cases
(S2 Fig). However, when pEM is applied to the data sets of case 3, the effect of analyzing a
Fig 2. pEM performance on synthetic protein trajectories with variable localization noise. (a) The probability distributions of each diffusive state
(shown in a different color) generated by the covariance-based estimator analysis on 10,000 protein trajectories for case 1 (left), case 2 (middle), and case 3
(right). The inset of each figure shows the total diffusivity distribution using the same scale as the main figure. (b-d) The average pEM estimates for each
diffusive state, (b) diffusivity, (c) population fraction, and (d) static localization noise, determined by analyzing data sets with various number of protein
trajectories given according to case 1 (left), case 2 (middle), and case 3 (right), assuming the correct model size for each case. Each color corresponds to a
different diffusive state (a-d). Each data point represents the average estimate from five sets of protein trajectories and the error bars represent the observed
standard deviation. The horizontal dashes represent the ground truth, i.e. the values input to the simulation, with the color corresponding to the diffusive state
in question. In some cases, the horizontal dashes cannot be seen when pEM yields estimates near the simulated values.
doi:10.1371/journal.pcbi.1004297.g002
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small number of protein trajectories results in unreliable parameter estimates (Fig 2b-2d,
right). Specifically, when 2,500 protein trajectories or less were analyzed, pEM failed to consis-
tently uncover all of the diffusive states, ultimately favoring a 6-diffusive-state model with
more-or-less erratic parameter values. The inclusion of a sufficiently large number of protein
trajectories, however, improved the accuracy and precision of the pEM estimates: When 5,000
protein trajectories or more were analyzed, pEM consistently uncovered a 7-diffusive-state
model with reliable parameter values. Evidently, if enough trajectories were available to ana-
lyze, pEM was consistently able to accurately characterize some diffusive states (namely 1, 2, 3,
and 7), despite the fact that some of these were under-represented, exhibiting population frac-
tions as low as 0.02. Not surprisingly, the greatest variability in the estimates came from the dif-
fusive states (namely 4, 5, and 6), which showed the most significantly overlapping component
distributions (green, cyan, and red curves in Fig 2a, right). States 1, 2, and 3, on the other hand,
lie close together in absolute terms, however the small widths of their diffusivity distributions
render them statistically distinguishable.
Comparison to other analysis methods in silico
To carry out a comparison of pEM to CDF and vbSPT, at a minimum, the static localization
noise must be known for each diffusive state in order to be able to correct for the biased diffu-
sivity estimates that emerge from CDF and vbSPT. Accordingly, we chose to simulate protein
trajectories without any interconversions exhibiting the same localization noise for all diffusive
states. For our CDF and vbSPT analyses, we took the localization noise to be known. For the
pEM analysis, however, we continued to employ our standard procedure, which determines
the static localization noise from the analysis itself.
When CDF is applied to 10,000 synthetic protein trajectories with diffusive states given
according to either case 1 or case 2, we found that CDF fails to uncover the proper number of
diffusive states, even when the simulation parameters are used as the initial fitting values (S2
Table). Nevertheless, the cumulative square displacements appear to be well fit with CDF (S3
Fig). When CDF is applied to protein trajectories without localization noise, for which CDF
models properly, the quality of the CDF estimates improves, albeit only for very large sample
sizes (S2 Table). Thus, CDF estimates should be treated with skepticism when trying to resolve
the diffusive states of experimental protein trajectories.
vbSPT, on the other hand, was occasionally able to uncover the correct numbers of diffusive
states with reasonably accurate parameter estimates, albeit after bias correction (S4 Fig). For
synthetic protein trajectories generated according to case 1, vbSPT uncovered the correct num-
ber of diffusive states only when less than 2,500 protein trajectories were analyzed (S5 Fig). Par-
adoxically, the inclusion of more trajectories introduced an additional, spurious diffusive state.
Specifically, the lowest diffusive state split into two distinct states with diffusivity values that lie
about the true value. For case 2, vbSPT uncovered three diffusive states only, when less than
2,500 protein trajectories were analyzed (S6 Fig). With the inclusion of more protein trajecto-
ries, however, vbSPT was able to uncover the proper number of diffusive states with accurate
estimates for the diffusivities. Even so, the population fraction estimates for the two slowest dif-
fusive states became progressively worse with the addition of more protein trajectories. For
case 3, vbSPT was only able to uncover 6 diffusive states even when analyzing 15,000 proteins
trajectories (S7 Fig).
In general, we found vbSPT captured the more mobile diffusive states accurately, but was
unsuccessful when applied to states with small diffusivities. Interestingly, among the states
with small diffusivities (Dk 0.1 μm2s−1), vbSPT nevertheless found significant transition
probabilities ( 0.1 per step) between diffusive states, despite the fact that each simulated
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protein trajectory corresponds to the same diffusive state throughout. When vbSPT was
applied to the same synthetic protein trajectories, but without localization noise, all diffusive
states were accurately recovered, including negligibly small transition probabilities (S8 Fig). In
the absence of localization noise, protein track displacements follow a Markov process. Thus,
vbSPT, and more generally hidden Markov models [41, 42], describe the underlying diffusion
process and kinetics accurately. However, experimental protein trajectories inevitably contain
localization noise which introduces correlations between nearest-neighbor displacements.
Thus, in general, analyses using standard hidden Markov models are only appropriate when
the localization noise sources are negligible.
On the surface, the problem of uncovering the numbers of diffusive states and determining
the properties of each diffusive state appears to be a cluster analysis problem [36]. Thus, the
most direct approach would be to calculate the CVE estimates for each individual protein tra-
jectory and apply a clustering algorithm to determine the underlying diffusive state properties
for each cluster. However, the distribution of diffusion coefficients is not Gaussian, especially
when the protein trajectories are short (S1 Text). Thus, applying a GMM approach on the
empirical diffusion coefficients and static localization noises is improper. Moreover, non-
parametric approaches, such as k-means clustering [36], also result in poor characterization of
the underlying diffusive state properties (S9 Fig).
Classification of protein trajectories to respective diffusive states
Beyond the identification of the diffusive states, that are present in the population of trajecto-
ries as a whole, it is also very interesting to consider the possibility of classifying individual pro-
tein trajectories into a particular diffusive state. In living cells, such a classification proffers the
ability to explore the spatiotemporal dynamics of each diffusive state separately, and to deter-
mine additional properties of each diffusive state, such as average duration, directionality, etc.
Fortunately, the posterior probability (Eq 4) gives the probability that a protein trajectory is
generated from a given diffusive state. Although it would be possible for classification to be
based on which state realizes the maximum posterior, information about the confidence of
each diffusive state is lost upon definitive classification, which in turn, may lead to artifacts.
Alternatively, the spatial distribution of the protein trajectories for each diffusive state may be
better represented by retaining all of the information by rendering each protein trajectory with
a color corresponding to the magnitude of the posterior probability as a heat map. The details
of such a representation are described in S4 Text.
Limitations of pEM
pEMmakes two broad assumptions: (1) the underlying diffusive states are normal, and (2)
there are no transitions between diffusive states. When these assumptions hold, we have shown
that pEM is able to uncover the proper number of diffusive states and yield an accurate charac-
terization of each diffusive state, that is, for protein trajectories with variable lengths similar to
our experimental data. In S5 Text, we explore pEM’s performance dependence on the protein
trajectories length. Since the width of the distribution of each underlying diffusive state is
directly related to the length of the protein trajectory (S1 Text), pEM performs better with lon-
ger protein trajectories. As the protein trajectories become shorter, the diffusivity distribution
of each diffusive state broadens leading to more overlap between diffusive states, thereby
increasing the complexity.
Longer protein trajectories, however, provide more opportunities for transitions between
diffusive states to occur. In S6 Text, we test pEM’s performance on synthetic protein trajecto-
ries which can transition between different diffusive states and for protein trajectories which
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contain a non-normal diffusive state. We find, in general, that even when transitions are pres-
ent, pEM still yields reasonable estimates for the underlying diffusivity and static localization
noise for each diffusive state. However, the population fractions become increasingly unreliable
when more transitions are present. In comparison, even though vbSPT incorporates the ability
to transition between diffusive states in principle, even in this case, we found that vbSPT still
underperforms pEM, which we attribute to its neglect of nearest-neighbor correlations.
Since transition rates and the presence of non-normal modes of diffusion are not known a
priori for experimental protein trajectories, we demonstrate how to test for transitions and for
the presence of non-normal modes of diffusion in S6 Text.
Application of pEM to Rho GTPase protein trajectories in live cells
As a first application of pEM to a biological system, we genetically tagged RhoA and RhoC to
the C-terminal of the photo-convertible mEos2 fluorophore and employed sptPALM to exam-
ine their single molecule membrane associated dynamics in live MCF10A human epithelial
cells, corresponding to a non-tumorigenic, spontaneously immortalized breast epithelial cell
line [43], resting on a glass surface. Fig 3a shows an image of a representative cell expressing
mEos2-RhoA observed in green light. The stochastic process of photoconversion alters the
fluorescence properties of a small portion of the population, such that under red light, individ-
ual Rho proteins can be reliably monitored without making any modifications to Rho’s endoge-
nous concentration levels (Fig 3b).
Membrane-associated Rho GTPases undergo numerous protein-protein interactions lead-
ing to variability in diffusive behaviors, which we envision to fall into three broad categories:
(1) active or inactive unbound Rho undergoing free diffusion along the membrane, (2) active
or inactive Rho bound to a single regulator/effector, undergoing reduced diffusion, and (3)
active Rho associated with large immobile macromolecular complexes. To explore the breadth
of Rho interactions, we investigated the diffusive behaviors of various point mutated functional
mutants each tagged with mEos2 fluorophore. For brevity, we will refer to these chimeras only
by their Rho designation henceforth. Specifically, the G14V point mutant represents a constitu-
tively activemutant incapable of GTP hydrolysis [44, 45], which we expect to be predominately
associated with macromolecular signaling complexes. The F30L mutant displays increased
GDP-to-GTP exchange rate, while maintaining normal GTP hydrolytic activity [46], leading to
spontaneous activation and effectively removing prolonged inactive states. The T19N mutant
is a dominant negative mutant with reduced binding affinity for GTP [45] and RhoGDI [47].
This mutation prevents activation and leads to strong binding to RhoGEFs [48]. To determine
what role the hypervariable (HV) domain plays in Rho diffusive dynamics, we generated trun-
cation mutants, which contain only the last seventeen C-terminal amino acids of RhoA or
RhoC fused to mEos2. Lastly, to extend our investigation into the role of the HV domain, we
generated a chimeric mutant consisting for the N-terminal G-protein domain of RhoC fused to
the HV domain of RhoA.
Unfortunately, the photoinstability of mEos2 prevented us from quantifying Rho’s resi-
dence time on the membrane. Specifically, we characterized Rho’s photostability using a pull
down-assay, immobilizing mEos2-RhoA on a glass surface, monitoring the fluorescence inten-
sity at each fluorescent spot over time, and employing a two-state hidden Markov Model to
extract the flurophore on-times and off-times (S10 Fig). The cumulative distribution functions
of the on- and off-times so-obtained were fit using a double exponential function (S10 Fig). For
both the on- and off-time distributions, the characteristic time of the fast component is shorter
than the 15 frame minimum cutoff, that we set for each protein trajectory. For the slowly-
decaying component, the off-time distribution showed a best-fit characteristic time of 3.2 s
Diffusive States of Rho GTPase
PLOS Computational Biology | DOI:10.1371/journal.pcbi.1004297 October 29, 2015 13 / 26
(100 frames), while the on-time distribution showed a best-fit characteristic time of 0.8 s (25
frames). This value for the on-lifetime is very similar to the characteristic duration of our
experimental protein trajectories in live cells, irrespective of mutation (Fig 3c), strongly sug-
gesting that the observed duration of these live-cell trajectories corresponds to the on-time of
the fluorophore, and therefore that the typical duration of Rho membrane association is signifi-
cantly longer than 0.8 s (25 frames). Only a subset of the observed fluorescent spots, namely
those that met our criterion for a minimum track length of 15 frames, were reconstructed into
protein trajectories (Fig 3b).
To compare ensemble differences in the diffusivities between various mutants, we generated
a cumulative distribution of diffusivities for each Rho variant by analyzing individual protein
trajectories with the covariance-based estimator [49] (Fig 3d and 3e). These distributions illus-
trate significant differences in the ensemble diffusive behavior among mutants. For instance,
the activating mutants, G14V and F30L, shift the population towards reduced diffusivities for
both RhoA and RhoC. Conversely, the dominate negative inactive mutant T19N, shifts the
Fig 3. Rho GTPase ensemble results. (a) Representative cell expressing mEos2-RhoA prior to photo conversion visualized under 488 nm TIRF
illumination. Scale bar is 10 μm. (b) The same cell after photoconversion now visualized under 561 nm TIRF illumination. The magnified selection depicts two
sufficiently long-lived fluorescent spots with their spatial trajectories shown in white. The fluorescent spots without a trajectory did not meet our criterion of a
minimum track length of 15 steps. Scale bar in the magnified image is 2 μm. (c) Empirical probability distribution of the protein trajectory durations of the RhoA
wild type+mutants (top) and RhoC wild type+mutants (bottom). (d-e) Cumulative probabilities of the diffusivity for (d) RhoA wild type+mutants and (e) RhoC
wild type+mutants from covariance-based estimator analysis on individual protein trajectories. The inset displays the corresponding binned probability
distributions. The error bars in the binned distributions represent the standard error of the mean (c-e). For each construct, we extracted protein trajectories
across several cells. The total numbers of trajectories analyzed for each construct is given in S3 Table.
doi:10.1371/journal.pcbi.1004297.g003
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population towards higher diffusivities for RhoA. Wild type RhoC, on the other hand, appears
nearly identical to RhoC T19N, with a slight divergence occurring at slower diffusivities. The
hypervariable truncation mutant, HV, for RhoA and RhoC, and RhoC Chimera HV, exhibit
population shifts towards even faster diffusivities relative to wild type. Interestingly, the major-
ity of the diffusivity distributions exhibit a bimodal shape (Fig 3d and 3e, inset). However, it
would be naive to infer on this basis that Rho experiences two main biochemical interactions,
because of the counterexample provided by the diffusivity distributions of the simulated pro-
tein trajectories for case 2 and case 3 (Fig 2a, inset), which also appear bimodel, but which in
fact correspond to significantly more complex diffusive heterogeneity. Clearly, diffusivity dis-
tributions are unreliable for resolving the system of diffusive states with fidelity.
Instead, to uncover the diffusive states, exhibited by Rho, we applied pEM to the population
of protein trajectories across multiple cells for each Rho variant (S3 Table).
To validate that the assumptions made by pEM hold for our experimental data, and also
bolstering our analysis methodology and the diffusive states that result, we verified a posteriori,
first, that the observed protein trajectories of Rho GTPase on average remain in the same state
diffusive state throughout, and secondly, that the underlying diffusion modes all correspond to
normal diffusion over the timescales relevant to our experiments (S7 Text). Example RhoA
protein trajectories for each diffusive state is shown in S1 Fig.
As shown in Table 1, in most cases, pEM uncovered six diffusive states ranging in diffusivity
from about 0.0007 μm2s−1 to about 0.7 μm2s−1. Strikingly, the diffusivity and localization noise
for each state are similar across all five mutants of RhoA and all six mutants of RhoC, strongly
suggesting that the same interactions are manifest within all of these variants. By contrast, the
population fractions of the different diffusive states vary significantly among the different vari-
ants (Fig 4). In general, Rho proteins reside predominantly in fast diffusing states (states 4–6)
Table 1. Diffusive states of Rho GTPases acquired via pEM. The diffusivities (μm2s−1), static localization noises (μm), and population fractions for RhoA,
RhoC, and various functional mutants are presented with a subscript corresponding to a respective diffusive state. Error bars are not presented for the rea-
sons stated in S3 Text.
RhoA RhoA
G14V
RhoA
F30L
RhoA
T19N
RhoA
HV
RhoC RhoC
G14V
RhoC
F30L
RhoC
T19N
RhoC
HV
RhoC Chimera
HV
D1 0.0002 0.0001 0.0001 0.0005 0.0002 0.0004 0.0020 0.0011 0.0011 0.0003 0.0012
D2 0.0194 0.0187 0.0148 0.0308 0.0189 0.0227 0.0335 0.0237 0.0300 0.0231 0.0357
D3 0.0779 0.0761 0.0704 0.0848 0.0836 0.0855 0.0899 0.0790
D4 0.1729 0.1538 0.1564 0.1726 0.1755 0.1856 0.1521 0.1503 0.1893 0.1533 0.1366
D5 0.3858 0.3468 0.3682 0.4340 0.4706 0.4173 0.3265 0.3122 0.4106 0.3359 0.3203
D6 0.6747 0.7259 0.6575 0.6749 0.7368 0.6331 0.5751 0.6112 0.5547 0.5576
σ1 0.0394 0.0398 0.0399 0.0397 0.0405 0.0384 0.0394 0.0409 0.0410 0.0403 0.0424
σ2 0.0572 0.0548 0.0577 0.0519 0.0543 0.0541 0.0455 0.0508 0.0534 0.0467 0.0505
σ3 0.0349 0.0338 0.0339 0.0355 0.0421 0.0367 0.0368 0.0397
σ4 0.0499 0.0503 0.0523 0.0472 0.0468 0.0508 0.0472 0.0500 0.0485 0.0434 0.0466
σ5 0.0520 0.0544 0.0579 0.0503 0.0505 0.0525 0.0486 0.0527 0.0538 0.0484 0.0521
σ6 0.0500 0.0532 0.0640 0.0535 0.0601 0.0710 0.0638 0.0794 0.0557 0.0554
π1 0.1727 0.2428 0.1884 0.1066 0.1020 0.1247 0.2336 0.1410 0.0842 0.0340 0.0914
π2 0.0661 0.1296 0.0963 0.0552 0.0377 0.0504 0.1992 0.1333 0.0492 0.0205 0.0583
π3 0.0279 0.0228 0.0145 0.0279 0.0304 0.1068 0.0668 0.0390
π4 0.1237 0.2065 0.1658 0.1293 0.0923 0.1894 0.2544 0.2476 0.2153 0.1029 0.0987
π5 0.4301 0.3403 0.4307 0.4414 0.4849 0.5498 0.2061 0.3227 0.5493 0.5259 0.2857
π6 0.1795 0.0580 0.1043 0.2395 0.2831 0.0553 0.0887 0.0630 0.3167 0.4659
doi:10.1371/journal.pcbi.1004297.t001
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across all variants, with the exception of RhoC G14V. Nevertheless, the activating mutants,
G14V and F30L, exhibit a decreased population of states 4–6 and a corresponding increase in
the populations of states 1 and 2, compared to the dominant negative mutant T19N, and the
HV truncation mutant, as we expected. These observations suggest that with activation, fewer
protein trajectories populate the faster diffusive states, implying that they are more likely to be
incorporated into binding interactions with large macromolecular complexes, resulting in a
reduced diffusivity and therefore a higher population of states 1 and 2. Interestingly, the vari-
ability of the population fractions between states 1 and 2 across the RhoA mutants was much
less pronounced, in comparison to the RhoC mutants. Moreover, wild type RhoA yields popu-
lation fractions intermediate between those of constitutively active, RhoA G14V mutant and
those of the dominant negative, RhoA T19N mutant. On the other hand, the population frac-
tions for wild type RhoC are more closely aligned with the dominant negative RhoC T19N.
To quantify the overall activation state of wild type cells, we carried out a least squares mini-
mization of the difference between the cumulative diffusivity distribution of wild type Rho
with the weighted sum of the cumulative diffusivity distributions of the activation extremes,
namely G14V and T19N, where the weights are the free parameters (S8 Text). This procedure
reveals that RhoA’s diffusive behavior was 32% similar to that of RhoA G14V and 68% similar
to that of RhoA T19N; while, RhoC exhibited a stronger imbalance with its behavior 5% similar
to that of RhoC G14V and 95% similar to that of RhoC T19N. Evidently, wild type RhoA
exhibits a significant population of both active and inactive states, albeit with a slight imbalance
towards inactive, in good agreement with our conceptual model (Fig 1). Wild type RhoC, on
the other hand, exhibits diffusive behaviors more closely aligned with global inactivation.
The spatial distribution of Rho proteins for each diffusive state, provided by the pEM’s pos-
terior-weighted classification (S4 Text), reveals that Rho proteins are ubiquitous across the
plasma membrane, irrespective of their activation state (S11 and S12 Figs). Moreover, we do
not observe any significant difference between the expression levels of RhoA and RhoC, nor
among the various mutants.
Fig 4. Diffusive state population fractions for Rho GTPase. Stacked bar graph of the population fractions
for each Rho GTPase determined via our pEM approach. The color corresponds to a given diffusive state.
The standard error for each diffusive state population fractions is < 0.02.
doi:10.1371/journal.pcbi.1004297.g004
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Discussion
Contrary to our expectations that HVmutants would undergo few protein-protein binding
interactions, and would therefore exhibit a limited number of diffusive states, Table 1 reveals
that HVmutants yielded nearly the same number of diffusive states as the full length Rho
mutants. This observation suggests that the majority of the diffusive states may be related to
interactions involving the HV domain and the heterogeneous environment of the plasma mem-
brane inside live cells [50, 51]. In particular, RhoA HV shows a significant population fraction of
very slow diffusive states (states 1 and 2), indicating its incorporation into large macromolecular
complexes. One possible explanation is the presence of an import phosphorylation site in
RhoA’s HV (S188) domain that is not found in RhoC. Phosphorylation of this site in RhoA has
been shown to act as an important negative regulatory signal, increasing RhoA’s affinity for
RhoGDI, leading to cytosolic sequestration [52]. It is conceivable that RhoA HV truncation
mutants can be recognized as substrate for kinases leading to binding and reduced diffusion.
cAMP-dependent kinase A (PKA) has been shown to phosphorylate RhoA on serine 188 [53].
PKA-anchoring proteins have also been described to provide spatiotemporal specificity for PKA
signaling by localizing PKA to specific cell organelles, including the plasma membrane [54].
Interestingly, RhoC HV, which does not have this phosphorylation site in its hypervariable
domain, yields significantly lower populations of states 1 and 2. Strikingly, RhoC Chimera HV,
which is constructed with the G-domain of RhoC and the hypervariable domain of RhoA, recov-
ers increased population fractions of the very slow diffusive states to similar levels as RhoA HV.
Although mutants with the HV tail alone may realize nearly all of the diffusive states found
in the intact Rho complex, the wide variability in the population fractions across different
mutants suggests that the HV tail is not solely responsible for the interactions of each diffusive
state. For instance, relative to their wild type counterparts, activating mutants, G14V and F30L,
yield larger population fractions of the very slow diffusive states (states 1 and 2), and smaller
population fractions of the fast diffusive states (states 4–6), while the reverse trend is observed
for the dominant negative mutant, T19N. State 3, on the other hand, was absent from HV
mutant populations suggesting that this state requires G-domain specific interactions.
Interestingly, state 1 and state 3, consistently yield a smaller static localization noise across
the full length Rho mutants (Table 1). We hypothesize that this result is because state 1 and
state 3 are prevalent on particular regions of the membrane, that are slightly closer to the
microscope coverslip, where the intensity of the exponentially-decaying evanescent TIRF exci-
tation is higher. In principle, the cell membrane may be locally closer to the coverslip near focal
adhesions, where Rho GTPases and integrins have been shown to play an interconnected role
in focal adhesion assembly [45, 55, 56]. The diffusive behavior of integrins has been reported to
undergo cycles of immobilization and free diffusion on focal adhesions with a reported diffu-
sion coefficient that is similar to the diffusivity that we find for state 3 [25]. Since the HV
mutants do not exhibit this population, we hypothesize that state 3 corresponds to the diffusion
of a small complex, perhaps with integrins themselves or some protein mediator [56, 57]. For
RhoA, a similar population fraction of state 3 is found across all variants, irrespective of activa-
tion state. RhoC, on the other hand, was more variable, yielding a significantly larger popula-
tion of state 3 for the activating mutants, G14V and F30L. By contrast, wild type RhoC and the
dominant negative RhoC (T19N) yielded lower population fractions of state 3, similar to
RhoA. Since overexpression of RhoC has been shown to lead to an increase in actin stress fiber
and focal adhesion contact formation [58], it is possible that RhoC has stronger interactions
with focal adhesions when activated. Although the T19N mutants are expected to be unable to
bind GTP or downstream effectors, the existence of these states may be the result of association
with membrane localized RhoGEF complexes [59, 60].
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Since constitutively active RhoA does not drive large scale population shifts to the slow dif-
fusive states (states 1 and 2) relative to wild type RhoA, we postulate that endogenous activa-
tion alone may not be a sufficient condition for efficient binding to downstream effectors.
Rather, a higher level of coordination with other signaling proteins is more likely to be
required to facilitate RhoA’s ability to bind to downstream effectors [61–63], and/or activate
the downstream effectors themselves [64, 65]. The high expression levels and ubiquitous spa-
tial distribution of RhoA throughout the cell may serve to enable a faster signaling response to
exogenous signals by removing the requirement of being recruited from greater distances
along the cell membrane. Although active RhoA does not efficiently bind to large macromo-
lecular complexes in the absence of exogenous stimuli, RhoA still likely undergoes a constant
cycling between active and inactive states as a regulatory mechanism to allow RhoA to be
readily available throughout the cell, but also to mitigate overreaction to spurious exogenous
stimuli.
On the other hand, constitutively active RhoC G14V can bind more efficiently to down-
stream effectors, even in a resting cell. Thus, RhoC may either have more available potential
downstream binding partners readily available, and/or RhoC does not require the same
extent of orchestration with other signaling proteins as RhoA. According to this point of
view, because RhoC exhibits similar high expression levels as RhoA, and is also ubiquitously
distributed throughout the cell, RhoC requires more stringent regulation to prevent
activation.
An important caveat to the present study stems from not knowing how the underlying bio-
logical signaling pathways may be altered with global activation [66], limiting the depth of
information that can be extracted. In addition, further controls, which perturb specific bio-
chemical interactions with potential downstream effectors, are undoubtedly required to deter-
mine what interactions correspond to each diffusive state. Finally, this study does not address
the role of RhoGDI, which enforces an additional level of regulation by shuttling Rho on and
off of the membrane, and possibly between different membrane domains [52].
Nevertheless, our study clearly demonstrates the power and potential of pEM by (1) uncov-
ering the number of diffusive states, (2) determining the properties of each such diffusive state,
and (3) classifying statistically each protein’s trajectory to a respective diffusive state. In the
future, it will be interesting to see how the propensities for each diffusive state change spatially
and temporally under various kinds of exogenous stimulation in both healthy and cancerous
cells. More generally, we envision that pEM will have a broad impact on studies of a wide range
of biological systems where different biochemical interactions result in distinct diffusive behav-
iors. The importance of uncovering the diffusive states of a protein, and eventually characteriz-
ing the transitions between different diffusive states within a protein’s trajectory is to permit
the endogenous in vivo biochemistry of the diffusing protein to be probed and monitored
within a live cell with single molecule resolution. Although pEM, in its current formulation,
does not yet include transitions between different diffusion states, the determination of the
number of diffusive states and their corresponding properties certainly brings us closer to real-
izing this transformational goal. Beyond single particle tracking data, pEM may help address
the general challenge of global maximization via EM.
Supporting Information
S1 Data. Matlab-based graphical user interface for pEM with working examples.
(ZIP)
S1 Table. Simulation parameters for synthetic particle trajectories. Diffusivities, static locali-
zation noises, and population fractions used to generate synthetic protein trajectories are
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presented for case 1, case 2, and case 3. The columns represent the set of parameter values for
each diffusive state.
(PDF)
S2 Table. CDF parameter estimates for synthetic particle trajectories. Dsim and πsim repre-
sent the parameters used to simulate 10,000 synthetic protein trajectories with motion blur
and a constant static localization noise, σsim = 0.05 μm, with diffusivities and population frac-
tions given according to case 1 and case 2. The cumulative distribution function (CDF)
parameter estimates are determined by applying a non-linear least squares fit to the cumula-
tive square displacements, Δr2 = Δx2 + Δy2, across the population of synthetic protein trajec-
tories according to [30]: CDFðDr2Þ ¼ 1 ðPKk¼1 pkeDr2=ð2rkÞÞ, where ρk = 2DkΔt
+ 2σ2 − 4RDkΔt, {Dk} are the diffusion coefﬁcients, and {πk} are the population fractions
which satisfy the normalization,
PK
k¼1 pk ¼ 1. Here, ρk and πk are the free parameters and the
normalization constraint for πk is enforced by replacing the population fraction of the Kth
diffusive state, πk, with 1
PK1
i¼1 pk . The ﬁt is applied over the range 0 to1. DCDF and πCDF
represent the CDF values from ﬁtting the cumulative square displacements of the synthetic
protein trajectories when using the simulated values as the initial guess and a known static
localization noise (S3 Fig). Dtrue and πtrue represent the CDF estimates when applied to the
same protein trajectories, but without localization noise, and using the simulated values as
the initial guess. Units of D, μm2s−1.
(PDF)
S3 Table. Numbers of Rho protein trajectories used for pEM analysis.
(PDF)
S1 Fig. Example single protein trajectories. Example single protein trajectories for each diffu-
sive state (shown in a different color) from synthetic protein trajectories given according to (a)
case 1, (b) case 2, and (c) case 3. The underlying diffusivity of each diffusive state increases
from left to right. (d) Shows example experimental RhoA trajectories based upon classification
to each diffusive state. Protein trajectories, which had a posterior probability greater than 0.95
for the given diffusive state, were randomly selected for case 1 and case 2. Protein trajectories
which have at least 40 steps and a posterior probability greater than 0.95 for the given diffusive
state, were randomly selected for case 3 and for the experimental RhoA trajectories. The scale
bar in each case represents 5 μm.
(TIFF)
S2 Fig. Bayesian information criterion scores for synthetic particle trajectories. BIC scores
for various model sizes, acquired by applying pEM to (left) 500 synthetic protein trajectories
corresponding to case 1 with a constant static localization noise, (middle) 1,000 synthetic pro-
tein trajectories corresponding to case 2 with a constant static localization noise, and (right)
5,000 synthetic protein trajectories corresponding to case 3 with variable static localization
noises. Each plot shows the BIC score from 10 different initial parameter values (each shown in
a different color). The maximum BIC score is consistently found for a four diffusive state
model for cases 1 and 2, and seven diffusive state model for case 3. Evidently since the variabil-
ity of the BIC score is smaller than its change for different number of states for all 3 cases, the
BIC is a reliable method for model selection in this case.
(TIFF)
S3 Fig. CDF of synthetic particle trajectories. The cumulative distribution of the square dis-
placements, determined from 10,000 synthetic protein trajectories, corresponding to case 1
(left) and case 2 (right), is shown as the blue curve, while the best fit CDF is shown as the red
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curve. The fitted parameters, namely the diffusivity, Dk, and the population fraction, πk, for
each diffusive state, k, are given in S2 Table.
(TIFF)
S4 Fig. vbSPT diffusivity estimates prior to bias correction for synthetic particle trajecto-
ries. Solid circles are the uncorrected diffusivity estimates, determined using vbSPT, for various
numbers of synthetic protein trajectories, corresponding to case 1 (left), case 2 (middle), and
case 3 (right). Different colors correspond to different diffusive states. Each data point repre-
sents the average of five sets of synthetic protein trajectories and the error bars represent the
standard deviation. Where the error bars are not visible, they are smaller than the symbol size.
The solid lines are a guide-to-the-eye. The horizontal dashed lines represent the ground truth,
i.e. the values of the diffusion coefficients that are input to the simulation. The color of each
dashed line indicates the corresponding underlying diffusive state. vbSPT was implemented
with the open-source software described in Ref. [32]. Since the vbSPT framework does not
directly incorporate localization noise, the diffusivity estimates generated by vbSPT are biased,
except at particular values of σ2 and D, at which the effects of static and dynamic localization
noise on-average cancel, i.e. for 2σ2 − 4DRΔt 0. For diffusivities below this threshold value,
the estimates exhibit a positive bias due to the dominant static localization noise. Above this
threshold value, the estimates exhibit a negative bias due to the dominant dynamic localization
noise.
(TIFF)
S5 Fig. Comparison of pEM and vbSPT for synthetic particle trajectories given according
to case 1. Diffusivity and population fraction estimates for various numbers of synthetic pro-
tein trajectories, corresponding to case 1, but with a constant static localization noise, σ = 0.05
μm, for pEM (left) and vbSPT (right). The static localization noise is assumed to be known for
vbSPT, but must be determined by pEM (bottom-left). Each color corresponds to a different
diffusive state. Each data point represents the average of five sets of synthetic protein trajecto-
ries and the error bars represent the observed standard deviations. The solid lines are guides-
to-the-eye. The horizontal dashed lines represent the ground truth, i.e. the values input to the
simulations. The color of each dashed line indicates the corresponding diffusive state. Because
the diffusivity estimates generated by vbSPT are biased, in order to present the analyis of pro-
tein trajectories with localization noise based on vbSPT, we propose a post hoc correction to the
diffusivity, determined by vbSPT, namely DvbSPTk , to mitigate the bias, namely Dk ¼
DvbSPT
k
Dts2
ð12RÞDt .
In this ﬁgure and in S6 and S7 Figs, the displayed results obtained using vbSPT have had this
correction applied.
(TIFF)
S6 Fig. Comparison of pEM and vbSPT for synthetic particle trajectories given according
to case 2. Diffusivity and population fraction estimates for various numbers of synthetic pro-
tein trajectories corresponding to case 2, but with a constant static localization noise, σ = 0.05
μm, for pEM (left) and vbSPT (right). The static localization noise is assumed to be known for
vbSPT but must be determined by pEM (bottom-left). Each color corresponds to a different
diffusive state. Each data point represents the average of five sets of synthetic protein trajecto-
ries and the error bars represent the observed standard deviations. The solid lines are guides-
to-the-eye. The horizontal dashed lines represent the ground truth, i.e. the values input to the
simulation. The color of each dashed line indicates the corresponding diffusive state.
(TIFF)
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S7 Fig. Comparison of pEM and vbSPT for synthetic particle trajectories given according to
case 3.Diffusivity and population fraction estimates for various numbers of synthetic protein tra-
jectories, corresponding to case 3, but with a constant static localization noise, σ = 0.05 μm, for
pEM (left) and vbSPT (right). The static localization noise is assumed to be known for vbSPT
but must be determined by pEM (bottom-left). Each color corresponds to a different diffusive
state. Each data point represents the average of five sets of synthetic protein trajectories and the
error bars represent the observed standard deviations. The solid lines are guides-to-the-eye. The
horizontal dashed lines represent the ground truth, i.e. the values input to the simulation. The
color of each dashed line indicates the corresponding diffusive state.
(TIFF)
S8 Fig. vbSPT parameter estimates for particle trajectories without localization noise. Dif-
fusivities and population fractions, given by vbSPT applied to various numbers of synthetic
protein trajectories without localization noise, corresponding to case 1 (left), case 2 (middle),
and case 3 (right). Each color corresponds to a different diffusive state. Each data point repre-
sents the average of five sets of synthetic protein trajectories and the error bars represent the
observed standard deviation. The solid lines are guides-to-the-eye. The horizontal dashed lines
represent the ground truth, i.e. the values input to the simulation. The color of each dashed line
indicates the corresponding diffusive state.
(TIFF)
S9 Fig. Performance of k-means clustering applied to synthetic particle trajectories.Diffusiv-
ity, static localization noise, and population fraction estimates for various numbers of synthetic
protein trajectories, corresponding to case 1 (left) and case 2 (right) determined on the basis of k-
means clustering applied to the diffusivity and static localization noise estimates for each protein
trajectory [36]. Here, the covariance-based estimator was used to determine the diffusivity and
static localization noise for each protein trajectory [49]. The k-means cluster for the correct model
size was employed with a random initialization for each data set. Each data point represents the
average of five sets of synthetic protein trajectories and the error bars represent the observed stan-
dard deviations. The solid lines are guides-to-the-eye. The horizontal dashed lines represent the
ground truth, i.e. the values input to the simulation. The color of each dashed line indicates the
simulated diffusive state. Each color of the k-means estimates corresponds to the closest diffusive
state, except that one of the diffusive states found by k-means clustering is so far away from any
actual diffusive state that it is given a different color (magenta). Because the performance of k-
means clustering is so poor for case 1 and case 2, we did not test this method for case 3.
(TIFF)
S10 Fig. Photostability of mEos2-RhoA. (a) Representative image from a pull-down assay of
mEos2-RhoA. The inset shows the intensity profile of a single fluorophore within the red box.
Scale bar is 10 μm. (b) Representative intensity time series taken from each point-spread func-
tion (blue) and the states found using hidden Markov models (red). (c) The cumulative distri-
bution of residence times in the on state (green) and the off state (blue). The fits represent a
two component cumulative exponential fits given by:
y ¼ 1 wexp ½t=t1  ð1 wÞexp ½t=t2;
where w represent the fraction of component 1 decays, and τ1 and τ2 correspond to the charac-
teristic residence times for component 1 and 2, respectively. The characteristic on-residence
times were τ1 = 0.26 s and τ2 = 0.79 s with w = 0.6. The characteristic off-residence times were
τ1 = 0.17 s and τ2 = 3.2 s with w = 0.33.
(TIFF)
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S11 Fig. Spatial distribution of RhoA protein trajectories within a representative cell. Each
column corresponds to a representative cell of RhoA, RhoA G14V, RhoA F30L, RhoA T19N,
and RhoA HV. For each of these cells, the top row shows 2,000 protein trajectories, rendered
using a false color scale, with the color corresponding to the diffusivity estimates found using
the CVE. The images shown in rows 2 through 7 constitute a posterior-weighted localization
map for each diffusive state in each cell. Specifically, the centroid of each protein trajectory is
rendered as a blue square with a transparency equal to one-third of the posterior probability
that the track in question realizes that row’s diffusive state. Thus, dark blue regions represent
regions inside the cell where there is a high posterior probability of finding one or more protein
trajectories corresponding to the diffusive state in question. Pale and white regions represent
regions of low and zero probability, respectively, to find a protein trajectory corresponding to
that diffusive state. The cell boundary is outlined in black in each panel. Scale bar is 10 μm.
(TIFF)
S12 Fig. Spatial distribution of RhoC protein trajectories within a representative cell. Each
column corresponds to a representative cell of RhoC, RhoC G14V, RhoC F30L, RhoC T19N,
RhoC HV, and RhoC Chimera HV. For each of these cells, the top row shows 2,000 protein tra-
jectories, rendered using a false color scale, with the color corresponding to the diffusivity esti-
mates found using the CVE. The images shown in rows 2 through 7 constitute a posterior-
weighted localization map for each diffusive state in each cell. Specifically, the centroid of each
protein trajectory is rendered as a blue square with a transparency equal to one-third of the
posterior probability that the track in question realizes that row’s diffusive state. Thus, dark
blue regions represent regions inside the cell where there is a high posterior probability of find-
ing one or more protein trajectories corresponding to the diffusive state in question. Pale and
white regions represent regions of low and zero probability, respectively, to find a protein tra-
jectory corresponding to that diffusive state. The cell boundary is outlined in black in each
panel. Scale bar is 10 μm.
(TIFF)
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